Article
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency.
British journal of clinical pharmacology - 1 Feb 2023
Maillard Maud, Launay Manon, Royer Bernard, Guitton Jérôme, Gautier-Veyret Elodie, Broutin Sophie, Tron Camille, Le Louedec Félicien, Ciccolini Joseph, Richard Damien, Alarcan Hugo, Haufroid Vincent, Tafzi Naïma, Schmitt Antonin, Etienne-Grimaldi Marie-Christine, Narjoz Céline, Thomas Fabienne
Abstract excerpt
AIMS: Determining dihydropyrimidine dehydrogenase (DPD) activity by measuring patient's uracil (U) plasma concentration is mandatory before fluoropyrimidine (FP) administration in France. In this study, we aimed to refine the pre-analytical recommendations for determining U and dihydrouracil (UH2 ) concentrations, as they are essential in reliable DPD-deficiency testing. METHODS: U and UH2 concentrations were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
